Results 101 to 110 of about 10,816 (168)

Pseudo-negative serum protein electrophoresis due to IgM aggregation in a patient with Waldenström macroglobulinemia: A case report. [PDF]

Medicine (Baltimore)
Xie H, He E, Quan H, Zhang S.
europepmc   +1 more source

Novel agents and evolving strategies in Waldenström macroglobulinemia: clinical trial updates from ASH 2025. [PDF]

Exp Hematol Oncol
Liang Y, Deng X, Wang Z, Xie C, Zheng L, Huang H, Yin S, Huang H.   +7 more
europepmc   +1 more source

Waldenström macroglobulinemia – between lymphoma and myeloma

Waldenströmova makroglobulinemija je rijedak indolentni B-stanični limfom koji je karakteriziran prisutnošću monoklonalnog imunoglobulina M u serumu i klonalnom proliferacijom limfoplazmocitoidnih stanica u koštanoj srži.
Galiot, Lucija
core   +2 more sources

Real-World Treatment Patterns for Waldenstrom Macroglobulinemia: Implications for Treatment Sequencing. [PDF]

J Korean Med Sci
Jang SY, Byun JM, Park SS, Kim Y, Park J, Shin DY, Koh Y, Kim I, Min CK, Yoon SS.   +9 more
europepmc   +1 more source

Treatment preferences in Waldenström macroglobulinemia: an international discrete choice experiment in 1455 patients. [PDF]

Blood Neoplasia
Becking AL, Nieuwkerk PT, Postek M, Amaador K, Bernelot Moens SJ, Bronsgeest L, D'Sa S, Faubert P, Harrington C, Kitchen P, MacDonald D, Minnema MC, McKinney A, Palomba ML, Tohidi-Esfahani I, Trotman J, Warden A, Kersten MJ, Vos JMI, WM-VOICE consortium.   +19 more
europepmc   +1 more source

Waldenström Macroglobulinemia Presenting With Hepatic Lesions: Case Report and Literature Review. [PDF]

Case Rep Hematol
Sternbach N, Bishara S, Gertz MA, Vaxman I.   +3 more
europepmc   +1 more source

Racial and socioeconomic disparities in patients with Waldenström Macroglobulinemia: a SEER database analysis. [PDF]

Sci Rep
Alvarez Soto A, Song J, Braun M, Kumar S.   +3 more
europepmc   +1 more source

POD24 is a novel determinant of prognosis in patients with Waldenström macroglobulinemia. [PDF]

Blood Adv
Zanwar S, Abeykoon J, D'Sa S, Roos-Weil D, Larson DR, Colby CL, Durot E, Kastritis E, Uppal E, Tomkins O, Morel P, Mondello P, Montes L, Paludo J, Ailawadhi S, Sarosiek S, Ogunbiyi O, Cornillet-Lefebvre P, Rajkumar SV, Quinquenel A, Dispenzieri A, Fonseca R, Gertz MA, Kumar S, Dimopoulos MA, Ansell SM, Treon S, Castillo JJ, Kapoor P.   +28 more
europepmc   +1 more source

Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-up. [PDF]

Blood Adv
Owen RG, McCarthy H, D'Sa S, Thomas SK, Tournilhac O, Forconi F, Kersten MJ, Zinzani PL, Iyengar S, Kothari J, Minnema MC, Kastritis E, Cheson BD, Walter HS, Greenwald D, Calvo R, Li Y, Rule S, Furman RR.   +18 more
europepmc   +1 more source

Cutaneous macroglobulinosis with Waldenström macroglobulinemia

JAAD Case Reports, 2020
Hussein M.M. Hassab-El-Naby, MD, Mohamed El-Khalawany, MD, Mahmoud A. Rageh, MSc   +2 more
doaj   +1 more source